Peritonsillar Phlegmon : An Addition to the Spectrum of COVID-19

Copyright © 2020, Khan et al..

The coronavirus disease 2019 (COVID-19) epidemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, then declared to be a pandemic associated with substantial morbidity and mortality. It has shown to exhibit a vast array of symptoms, among which fever, shortness of breath, and cough are the most commonly reported. Lymphadenopathy and tonsillar enlargement is a less common finding reported with this infection. This case describes a patient with tonsillar inflammation which was complicated by peritonsillar phlegmon, with negative throat culture and positive COVID-19 test, suggesting a COVID-19-related etiology of the disease. After the literature search, to the best of our knowledge, this is the first reported case of COVID-related peritonsillar inflammation and phlegmon formation.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Cureus - 12(2020), 12 vom: 29. Dez., Seite e12369

Sprache:

Englisch

Beteiligte Personen:

Khan, Muhammad Atique Alam [VerfasserIn]
Rosal, Nathaniel [VerfasserIn]
Iqbal, Iqra [VerfasserIn]
Minalyan, Artem [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Covid-19
Lymphadenopathy
Peritonsillar phlegmon
Tonsillitis

Anmerkungen:

Date Revised 03.02.2021

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.7759/cureus.12369

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320880508